Skip to content

Home
Receipts
Watchlist

About
Get involved

Privacy first · Built by HelloJoal · assisted by AI

Home
Receipts
Watchlist

SB 2951: Annual Marketing Expenses Report for Drug Manufacturers Act of 2011 · CivicSync PH

SB 2951

Senate·15th Congress·Filed Aug 23, 2011

Annual Marketing Expenses Report for Drug Manufacturers Act of 2011

An Act to Require Manufacturers, Distributors and Labelers of Prescription Drugs to Report Their Annual Marketing Costs

Status

Live status tracking covers the 20th Congress only. See the official record below for this bill’s final outcome.

Author · Senator

Manny Villar
SenatorManuel "Manny" Villar Jr
Receipts →

Author · Senator

Manny Villar
SenatorManuel "Manny" Villar Jr
Receipts →

Subjects

MedicinesDrugs

Official sources

Senate record
Bill text (PDF)

Spot something wrong?

Printed from CivicSync PH: https://civicsync-ph-gamma.vercel.app/bills/01K67YJ9ANQBWV5H6HXZX65Z12. Status changes over time; check the link for the latest.

SBN-02951 · Sources: BetterGov Open Congress

Related bills · 20th Congress

Similar in what they’d do, filed by any lawmaker.

HB 4259· Filed Sep 1, 2025
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2025-09-03Rep. Ferdinand Martin G. Romualdez +3
HB 8552· Filed Mar 16, 2026
An Act Strengthening Domestic Pharmaceutical Manufacturing, Ensuring Medicines Supply Security, and Supporting the Sustainability of Universal Health Care
Pending with the Committee on HEALTH since 2026-03-18Rep. Girlie E. Veloso
HB 9221· Filed May 12, 2026
An Act to Accelerate the Discovery and Development of Innovative Medicines by Strengthening Clinical Trials, and for Other Purposes
Pending with the Committee on HEALTH since 2026-05-18Rep. Florabel C. Yatco
SB 1169· Filed Aug 11, 2025
Drugs and Medicines Price Regulatory Board
Pending in the committeeSen. Imee R. Marcos
HB 3868· Filed Aug 20, 2025
An Act Increasing Access to Cancer and Related Care Medicines by Mandating an Automatic or Expedited Licensing and Registration Process of Antineoplastic Drugs Sourced Overseas, While Ensuring Their Availability at Affordable Prices, Appropriating Funds Therefor, Amending for the Purpose Republic Act No. 11215, Otherwise Known as "National Integrated Cancer Control Act"
Pending with the Committee on HEALTH since 2025-08-27Rep. Stephen James T. Tan